287 related articles for article (PubMed ID: 7012258)
21. [Trial with a new anti-nausea regime].
Midgaard T
Fag Tidsskr Sykepleien; 1990 Nov; 78(8):15, 29. PubMed ID: 2271331
[No Abstract] [Full Text] [Related]
22. Measurement of success: parameters of efficacy.
de Mulder PH
Br J Cancer Suppl; 1992 Dec; 19():S68. PubMed ID: 1467205
[No Abstract] [Full Text] [Related]
23. Antiemetic therapy in patients treated with cisplatin chemotherapy.
Roila F; Basurto C; Bracarda S; Del Favero A; Tonato M
J Chemother; 1989 Jul; 1(4 Suppl):1281-5. PubMed ID: 16312866
[No Abstract] [Full Text] [Related]
24. Nausea and vomiting associated with cancer chemotherapy: drug management in theory and in practice.
Antonarakis ES; Hain RD
Arch Dis Child; 2004 Sep; 89(9):877-80. PubMed ID: 15321871
[TBL] [Abstract][Full Text] [Related]
25. [The prevention of nausea and vomiting induced by antineoplastic chemotherapy: the state of the art].
Roila F; Tonato M; Del Favero A
Riv Inferm; 1991; 10(1):40-3. PubMed ID: 1853098
[No Abstract] [Full Text] [Related]
26. A study evaluating the efficacy and tolerability of tropisetron in combination with dexamethasone in the prevention of delayed platinum-induced nausea and emesis.
Sorbe BG; Berglind AM; Andersson H; Boman K; Högberg T; Hallgren M; Schmidt M
Cancer; 1998 Sep; 83(5):1022-32. PubMed ID: 9731907
[TBL] [Abstract][Full Text] [Related]
27. Randomized, double-blind, dose-finding study of dexamethasone in preventing acute emesis induced by anthracyclines, carboplatin, or cyclophosphamide:
Italian Group For Antiemetic Research
J Clin Oncol; 2004 Feb; 22(4):725-9. PubMed ID: 14966097
[TBL] [Abstract][Full Text] [Related]
28. Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting. Results from a randomized, double-blind, placebo-controlled trial in Latin America.
Poli-Bigelli S; Rodrigues-Pereira J; Carides AD; Julie Ma G; Eldridge K; Hipple A; Evans JK; Horgan KJ; Lawson F;
Cancer; 2003 Jun; 97(12):3090-8. PubMed ID: 12784346
[TBL] [Abstract][Full Text] [Related]
29. Antiemetic Prophylaxis for Chemotherapy-Induced Nausea and Vomiting.
Navari RM; Aapro M
N Engl J Med; 2016 Apr; 374(14):1356-67. PubMed ID: 27050207
[No Abstract] [Full Text] [Related]
30. CLINICAL DECISIONS. Chemotherapy-Induced Nausea and Vomiting.
Wilbur MB; Birrer MJ; Spriggs DR
N Engl J Med; 2016 Jul; 375(2):177-9. PubMed ID: 27410928
[No Abstract] [Full Text] [Related]
31. Antiemetic study design: a discussion of Dr Olver's paper.
Groshen S
Br J Cancer Suppl; 1992 Dec; 19():S35-7. PubMed ID: 1467199
[No Abstract] [Full Text] [Related]
32. Chemotherapy-induced nausea and vomiting. Easing patients' fear and discomfort with effective antiemetic regimens.
Bilgrami S; Fallon BG
Postgrad Med; 1993 Oct; 94(5):55-8, 62-4. PubMed ID: 8415336
[TBL] [Abstract][Full Text] [Related]
33. [Croatian guideliness for prevention of chemotherapy induced nausea and vomiting].
Tomek R; Vrdoljak E; Vrbanec D; Nemet D; Matković V; Plestina S; Gugić D; Dintinjana RD; Bolanca A; Samarzija M; Petković M
Lijec Vjesn; 2009; 131(3-4):49-53. PubMed ID: 19514248
[TBL] [Abstract][Full Text] [Related]
34. Infusion of palonosetron plus dexamethasone for the prevention of chemotherapy-induced nausea and vomiting.
Hajdenberg J; Grote T; Yee L; Arevalo-Araujo R; Latimer LA
J Support Oncol; 2006 Oct; 4(9):467-71. PubMed ID: 17080735
[TBL] [Abstract][Full Text] [Related]
35. Comparison of dexamethasone and metoclopramide as antiemetics in children receiving cancer chemotherapy.
Basade M; Kulkarni SS; Dhar AK; Sastry PS; Saikia B; Advani SH
Indian Pediatr; 1996 Apr; 33(4):321-3. PubMed ID: 8772908
[No Abstract] [Full Text] [Related]
36. The influence of dexamethasone in the decrease of chemotherapy-induced nausea and vomiting.
Sarcev T; Secen N; Povazan Dj; Sabo A; Popovic J; Bursac D; Kakas M; Zaric B; Milovancev A
J BUON; 2007; 12(2):245-52. PubMed ID: 17600880
[TBL] [Abstract][Full Text] [Related]
37. Combination therapy for chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy: palonosetron, dexamethasone, and aprepitant.
Grote T; Hajdenberg J; Cartmell A; Ferguson S; Ginkel A; Charu V
J Support Oncol; 2006 Sep; 4(8):403-8. PubMed ID: 17004515
[TBL] [Abstract][Full Text] [Related]
38. Phase II trial of ramosetron plus dexamethasone in the prevention of cisplatin-induced nausea and vomiting.
Voravud N; Sriuranpong V
J Med Assoc Thai; 2005 Dec; 88(12):1790-6. PubMed ID: 16518975
[TBL] [Abstract][Full Text] [Related]
39. Hypnosis in the prevention of chemotherapy-related nausea and vomiting in children: a prospective study.
Jacknow DS; Tschann JM; Link MP; Boyce WT
J Dev Behav Pediatr; 1994 Aug; 15(4):258-64. PubMed ID: 7798371
[TBL] [Abstract][Full Text] [Related]
40. Study of efficacy and tolerability of tropisetron in the prevention of cisplatin induced nausea and vomiting.
Chiersilpa A; Ngow J
J Med Assoc Thai; 1999 Sep; 82(9):915-21. PubMed ID: 10561949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
